GET A FREE BUSINESS VALUATION WITH IN 24 HOURS CLICK HERE X Dismiss
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2024 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
Empresa de biotecnologia com um excelente histórico de segurança de mais de 2500 tratamentos clínicos. A empresa projeta, fabrica e comercializa produtos de filtragem sanguínea por afinidade. Um novo e altamente inovador dispo ...
A indústria farmacêutica indiana emergiu como um jogador global nas últimas décadas, tornando-se um dos maiores produtores de medicamentos genéricos em todo o mundo. O negócio dos medicamentos indianos testemunhou um crescim ...
Empresa de biotecnologia com um excelente histórico de segurança de mais de 2500 tratamentos clínicos. A empresa projeta, fabrica e comercializa produtos de filtragem sanguínea por afinidade. Um novo e altamente inovador dispositivo de hemofiltração que utiliza tecnologia biomimética patenteada e proprietária para remover rapidamente bactérias, fungos, toxinas bacterianas, vírus, citocinas pró-inflamatórias e mediadores de sepse de um paciente que sofre de infecção na corrente sanguínea.
Atratividade para Investimento
Milhões de pacientes afetados globalmente pelo mercado de sepse, com mais de 30 milhões de casos por ano.
Outras aplicações dessa tecnologia podem ser usadas como contramedida para ataques biológicos (COVID), câncer de PDAC, para prevenir os efeitos colaterais do uso de ECMO e circulação extracorpórea em diagnósticos, bancos de sangue e bioprocessamento.
Apenas um múltiplo de 10 vezes o lucro líquido acumulado poderia avaliar a empresa em até US$ 40 bilhões até o final de 2028.
Oportunidade de crescimento
Gestão sólida
Margens de lucro bruto >85%
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://mergerscorp.com/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
This website is operated by MergersUS Inc a US Corporation with registered office at
Erro: Formulário de contato não encontrado.
Erro: Formulário de contato não encontrado.
Erro: Formulário de contato não encontrado.
Erro: Formulário de contato não encontrado.